story of the week
IL-6 Receptor Antagonists in Severe COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Interleukin-6 Receptor Antagonists in Critically Ill Patients With Covid-19
N. Engl. J. Med 2021 Feb 25;[EPub Ahead of Print], , AC Gordon, PR Mouncey, F Al-Beidh, KM Rowan, AD Nichol, YM Arabi, D Annane, A Beane, W van Bentum-Puijk, LR Berry, Z Bhimani, MJM Bonten, CA Bradbury, FM Brunkhorst, A Buzgau, AC Cheng, MA Detry, EJ Duffy, LJ Estcourt, M Fitzgerald, H Goossens, R Haniffa, AM Higgins, TE Hills, CM Horvat, F Lamontagne, PR Lawler, HL Leavis, KM Linstrum, E Litton, E Lorenzi, JC Marshall, FB Mayr, DF McAuley, A McGlothlin, SP McGuinness, BJ McVerry, SK Montgomery, SC Morpeth, S Murthy, K Orr, RL Parke, JC Parker, AE Patanwala, V Pettilä, E Rademaker, MS Santos, CT Saunders, CW Seymour, M Shankar-Hari, WI Sligl, AF Turgeon, AM Turner, FL van de Veerdonk, R Zarychanski, C Green, RJ Lewis, DC Angus, CJ McArthur, S Berry, SA Webb, LPG DerdeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.